Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy
Xingmei Duan,1,2,* Minjie Mu,3,* Junfeng Yan,1 Lan Bai,1 Lei Zhong,1 Yuxuan Zhu,1 Haixia Pan,1 Mei Zhang,3 Jianyou Shi1,3 1Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People`s Hospital, Chengdu, 2State Key Laboratory of Biotherapy and Can...
Main Authors: | Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-03-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/co-delivery-of-aurora-a-inhibitor-xy-4-and-bcl-xl-sirna-enhances-antit-peer-reviewed-article-IJN |
Similar Items
-
Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis
by: Liang Xiaohui, et al.
Published: (2012-07-01) -
Aurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindle
by: Helfrid Hochegger, et al.
Published: (2013-01-01) -
Aurora kinases orchestrate mitosis; who are the players?
by: Molla Annie
Published: (2010-08-01) -
The functional diversity of Aurora kinases: a comprehensive review
by: Estelle Willems, et al.
Published: (2018-09-01) -
Aurora B Inhibitors as Cancer Therapeutics
by: Antal H. Kovacs, et al.
Published: (2023-04-01)